0: For the first time, we combined iTRAQ8-plex labeling with liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a quantitative proteomics analysis approach to compare protein abundance in the serum and urine samples of healthy controls to that in the serum and urine samples of stage I, II, III, and IV lung adenocarcinoma patients.
1: The purpose of this study was to identify a set of biomarkers for the early diagnosis and metastasis prediction in patients with lung adenocarcinoma using serum and urine.
